With the acquisition of LOG Pharma, the CPH Group (Perlen Packaging) is systematically expanding its market presence in high-growth regions and strategically extending its packaging portfolio for the pharmaceutical and medical industries.
CPH Group AG is an internationally active industrial group headquartered in Switzerland. It is active in the chemicals and pharmaceutical packaging sectors and operates sites in Switzerland, Germany, Bosnia-Herzegovina, the USA, Brazil, China and India. The company employs a total of 904 people (as at June 30, 2024).
With the acquisition of LOG Pharma, the CPH Group is strengthening its market presence in growth regions and expanding its packaging division. Despite the political uncertainties in Israel, the company considers the strategic opportunities of the acquisition to outweigh the risks.
Perlen Packaging is the packaging division of the CPH Group and the world's third largest supplier of coated films for the pharmaceutical industry. The company produces a wide range of products from PVC monofilms to high-barrier coated PvdC films, which are primarily used for blister packaging of medicines.
Perlen Packaging operates five production sites in Switzerland, Germany, the USA, China and Brazil. With the acquisition of LOG Pharma, the company is adding vials and containers as primary pharmaceutical packaging to its portfolio and expanding its presence in Israel and Hungary.
LOG Pharma is a manufacturer of packaging solutions for the pharmaceutical and medical industries. The company develops and produces innovative packaging solutions with outstanding barrier properties against oxygen and water vapor. These ensure the safe and long-term storage of both liquid and solid medicines and meet the highest requirements of the pharmaceutical and medical industries.
LOG Pharma operates two production sites in Israel and Hungary and employs a total of 245 people (130 in Israel, 115 in Hungary). In 2023, the company generated sales of CHF 26 million and EBITDA of CHF 2.7 million - the parties have agreed not to disclose the purchase price.
With the acquisition by Perlen Packaging, LOG Pharma will remain on the market under its own name, enabling the CPH Group to enter the Eastern European pharmaceutical packaging market.
ConAlliance is a leading M&A advisory firm specializing in the healthcare sector, including the pharmaceutical industry and the medical packaging sector. The company has in-depth expertise in the life sciences industry and a global network that enables customized solutions for complex transactions. By combining traditional M&A advisory and transaction services with in-depth industry know-how, ConAlliance supports mergers, acquisitions and divestitures.